SYVC OTC
Synovics Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$4M
+204.9% ▲
Capital Expenditures
$708K
+0.2% ▲
5Y CAGR: +47.9%
Free Cash Flow
$3M
+171.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$66K
+102.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$3M | -$9M | -$21M | -$4M |
| Depreciation & Amort. | $31K | $72K | $1M | -$335K | $611K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$36K | $176K | $1M | $5M | -$427K |
| Other Non-Cash Items | $489K | $405K | $1M | $13M | $8M |
| Operating Cash Flow | -$640K | -$2M | -$5M | -$4M | $4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$238K | -$2M | -$710K | -$708K |
| Acquisitions (Net) | $0 | -$112K | -$9M | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$10K | $0 | -$9M | $0 | $0 |
| Investing Cash Flow | -$13K | -$350K | -$10M | -$710K | -$708K |
| — Financing Activities — | |||||
| Net Debt Issuance | $80K | $2M | $13M | $173K | -$10M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$841K | $0 | $0 |
| Financing Cash Flow | $1M | $2M | $18M | $2M | -$3M |
| Net Change in Cash | $626K | -$500K | $2M | -$2M | $66K |
| Cash End of Period | $629K | $129K | $2M | $0 | $66K |
| Free Cash Flow | -$654K | -$2M | -$7M | -$4M | $3M |